Influence of admission glucose level on long-term prognosis in patients with acute coronary syndrome;Influencia de la concentración de glucemia en el momento del ingreso en la evolución a largo plazo de los pacientes con síndrome coronario agudo

Revista Espanola de Cardiologia

Volumn 59, Issue 12, 2006, Pages 1268-1275

  Macín, Stella M ^a   Perna, Eduardo R ^a   Coronel, María L ^a   Kriskovich, Jorge O ^a   Bayol, Pablo A ^a   Franciosi, Valeria A ^a   Riera Stival, Jorge L ^a   González Arjol, Bilda ^a   Badaracco, Jorge R ^a  

^a Instituto de Cardiología Juana F Cabral ^*  (Argentina)

Author keywords

Acute coronary syndrome; Glycemia; Hyperglycemia; Prognosis

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOLYTIC AGENT; GLUCOSE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TROPONIN T;

ACUTE CORONARY SYNDROME; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; SYMPTOM; SYSTOLIC BLOOD PRESSURE; UNSTABLE ANGINA PECTORIS;

EID: 33846684462     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13096598     Document Type: Article

References (42)

1. Klamann A, Sarfert P, Schulte G, Launhardt V, Schemiegel W, Nauck MA. Myocardial infarction in diabetic versus non-diabetic subjects: relation of survival and infarct size following theraphy with sulfonylurea (glibenclamida). Eur Heart J. 2000;21:220-9.
2. Meier JJ, Deifuss S, Klamann A, Launhardt V, Schmiegel WH, Nauck MA. Plasma glucose at hospital admission and previous metabolic control determine myocardial infarct size and survival in patients with and without type 2 diabetes. Diabetes Care. 2005;28:2551-3.
3. Iwakura K, Ito H, Ikushima M, Kawano S, Okamura A, Asano K, et al. Association between hyperglycemia and the no reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol. 2003;41:1-7.
4. Bolk J, Van der Ploeg T, Coronel JH, Arnold AE, Sepers J, Uman VA. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol. 2001;79:207-14.
5. Capes S, Hunt D, Malmberg K, Gerstein H. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773-8.
6. Ceriello A. Acute hyperglycaemia: a «new» risk factor during myocardial infarction. Eur Heart J. 2005;26:328-31.
7. Nazneen N, Cowden E, Pearce N, Gardner M, Merry H, Cox J. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol. 2002;40:1748-54.
8. Kosiborod M, Rathore S, Inzucchi S, Masoudi F, Wang Y, Havranek E. Admission glucose and mortality in elderly patients hospitalized wih acute myocardial infarction. Circulation. 2005;111:3078-86.
9. Suleiman M, Hammerman H, Boulos M, Kapeliovich M, Suleiman A, Agmon Y, et al. Fasting glucose is an important independent risk factor for 30 day mortality in patients with acute mycardial infarction. Circulation. 2005;111:754-60.
10. Depre C, Vanoverschelde JL, Taegtmeyer H. Glucose for the heart. Circulation. 1999;99:578-88.
11. Macín SM, Perna ER, Augier N, Cialzeta J, Farías EF, Fontana M, et al. Características clínicas y evolución a largo plazo de pacientes con insuficiencia cardiaca como complicación del infarto agudo de miocardio. Rev Esp Cardiol. 2005;58:789-96.
12. Lopaschuk G, Stanley W. Glucose metabolism in the ischemic heart. Circulation. 1997;95:313-5.
13. Taegtmeyer H, McNulty P, Young M. Adaptation and maladaptation of tbe heart in diabetes: Part I. General concepts. Circulation. 2002;105:1727-33.
14. Monteiro P, Goncalves L, Providencia LA. Diabetes and cardiovascular disease: the road to cardioprotection. Heart. 2005;91:1621-5.
15. Bartnik M, Malmberg K, Ryden L. Managing heart disease diabetes and the heart: compromised myocardial function-a common challenge. Eur Heart J. 2003;5 Suppl B:33-41.
16. Bolk J, Van der Ploeg T, Cornel J, Arnold A, Sepers J, Umans V. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol. 2001;79:207-14.
17. Williams S, Goldfine A, Timimi F, Ting H, Roddy M, Simonson D, et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation. 1998;97:1695-701.
18. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL. On behalf of the ICONS Investigators. J Am Coll Cardiol. 2002;40;1748-54.
19. Stentz F, Umpierrez G, Cuervo R, Kitabchi A. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes. 2004;53:2079-86.
20. Chaudhuri A, Janicke D, Wilson M, Tripathy D, Garg R, Bandyopadhyay A, et al. Anti-inflammatory and profibrinolytic effect of insulin in acute ST segment elevation myocardial infarction. Circulation. 2004;109:849-54.
21. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002;359:2140-4.
22. Marfella R, Siniscalchi M, Esposito K, Sellitto A, De Fanis U, Romano C, et al. Effects of stress hyperglycemia on acute myocardial infarction. Diabetes Care. 2003;26:3129-35.
23. Jagasia D, Whiting J, Concato J, Pfau S, McNulty P. Effect of non-insulin-dependent diabetes mellitus on myocardial insulin responsiveness in patients with ischemic heart disease. Circulation. 2001;103:1734-9.
24. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL, and ICONS Investigators. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol. 2002;40:1748-54.
25. Pajunen P, Koukkunen H, Ketonen M, Jerkkola T, Immonen-Raiha P, Karja-Koskenkari J, et al. Myocardial infarction in diabetic and non-diabetic persons with and without prior myocardial infarction: the FINAMI Study. Diabetologia 2005;48:2519-24.
26. Wu A, Parsons L, Every N, Bates E. Hospital outcome in patients presenting with congestive heart failure complicating acute myocardial infarction. A report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol. 2002:40:1389-94.
27. Hellermann JP, Jacobsen SJ, Gersh BJ, Rodeheffer RJ, Reeder GS, Roger VL. Heart failure after myocardial infarction: a review. Am J Med. 2002;113:324-30.
28. Dargie H. Heart failure post-myocardial infarction: a review of issues. Heart. 2005;91 Suppl II:3-6
29. Heidenreih PA, Alloggiamento T, Melsop K, McDonald KM, Go A, Hlatky MA. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol. 2001;38:478-85.
30. Magnus Ohman E, Armstrong PW, White HD, Granger CHB, Wilcox RG, Douglas Weaver W, et al. Risk stratification with a point of care cardiac troponin T test in acute myocardial infarction. Am J Cardiol. 1999;84:1281-6.
31. Bueno, H. Prevención y tratamiento de la cardiopatía isquemica en pacientes con diabetes mellitus. Rev Esp Cardiol. 2002; 55:975-86.
32. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57-65.
33. Mehta SR, Yusuf S, Díaz R, Zhu J, Pais, Xavier D, et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: The CREATE-ECLA Randomized Controlled Trial. JAMA. 2005;293:437-46.
34. Wang P, Chatman J. Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart. Am J Physiol Endocrinol Metabolism. 2004;286:E725-36.
35. Van der Horst I, Zijlstra F, Van't Hof A, Doggen C, De Boer M, Suryapranata H, et al. Glucose-insulin-potassium infusion in patients treated with primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2003;42:784-91.
36. Bloomgarden Z. Inpatient diabetes control. Diabetes Care. 2004;27:2272-7.
37. Giuliano R, Branunwald E. The year in non-ST-Segment elevation acute coronary syndromes. J Am Coll Cardiol. 2005;46:906-19.
38. Schwartz GG, Olsson AG. The case for intensive statin theraphy after acute coronary syndromes. Am J Cardiol. 2005;96:45F-53F.
39. De Winter R, Windhausen F, Coronel JH, Dunselman PHJM, Janus CH, Bendermacher PEF, et al. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med. 2005;353:1095-104.
40. Chen ZM, Pan HC, Chen YP, Peto R, Collins R, Jiang LX, et al. COMIT (Clopidogrel and metoprolol in myocardial infarction trial) collaborative group. Early intravenous then oral metoprolol in 45.852 patients with acute myocardial infarction: randomized placebo-controlled trial. Lancet. 2005;366:1622-32.
41. Zamora A, Marrugat J. Pronóstico de los pacientes diabéticos con cardiopatía isquémica. Rev Esp Cardiol. 2002;55:751-62.
42. Jiménez-Navarro M, Curiel E, Hernández García J, Briales J, Domínguez Franco A, Gómez Doblas J, et al. Influencia de la diabetes mellitus en los resultados clínicos tras revascularización coronaria percutánea. Rev Esp Cardiol. 2002;55:365-71.